Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$16.71 - $106.24 $977,852 - $6.22 Million
-58,519 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$20.24 - $29.16 $1.03 Million - $1.48 Million
50,719 Added 650.24%
58,519 $1.18 Million
Q2 2019

Aug 14, 2019

SELL
$13.46 - $25.75 $2.77 Million - $5.3 Million
-205,845 Reduced 96.35%
7,800 $201,000
Q1 2019

May 14, 2019

BUY
$2.63 - $16.34 $561,886 - $3.49 Million
213,645 New
213,645 $3.04 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.84B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.